Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

ABBOTT LABORATORIES Director's Dealing 2014

Feb 19, 2014

29777_rns_2014-02-19_6195b674-824f-4610-975e-96cea4f26467.pdf

Director's Dealing

Open in viewer

Opens in your device viewer

Page 1 of 2

SEC FORM 4

SEC Form 4 FORM 4

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

UNITED STATES SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL OMB Number: 3235-0287 December 31, Expires: 2014 Estimated average burden hours per 0.5 response:

or Section 30(h) of the Investment Company Act of 1940 or Section 30(h) of the Investment Company Act of 1940 or Section 30(h) of the Investment Company Act of 1940 or Section 30(h) of the Investment Company Act of 1940 or Section 30(h) of the Investment Company Act of 1940 or Section 30(h) of the Investment Company Act of 1940
1. Name and Address of Reporting Person*Contreras Jaime(Last)(First)(Middle)100 ABBOTT PARK ROAD(Street)ABBOTTPARKIL60064(City)(State)(Zip) 2. Issuer NameandTicker or Trading SymbolABBOTT LABORATORIES[ABT] 5. Relationship of Reporting Person(s) to Issuer(Check all applicable)Director10% OwnerXOfficer (give titlebelow)Other (specifybelow)Senior Vice President
3. Date of Earliest Transaction (Month/Day/Year)02/15/2014
4. If Amendment, Date of Original Filed (Month/Day/Year) 6. Individual or Joint/Group Filing (CheckApplicable Line)XForm filed by One Reporting PersonForm filed by More than One ReportingPerson
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. TransactionDate(Month/Day/Year) 2A. DeemedExecution Date,if any(Month/Day/Year) 3.TransactionCode (Instr.8) 4. Securities Acquired (A)or Disposed Of (D) (Instr.3, 4 and 5) 5. AmountofSecuritiesBeneficiallyOwnedFollowingReportedTransaction(s) (Instr. 3and 4) 6.OwnershipForm:Direct (D)or Indirect(I) (Instr. 4) 7. Nature ofIndirectBeneficialOwnership(Instr. 4)
Code V Amount (A)or(D) Price
Common shares without par value 23,733 D
Common shares without par value 20(1) I ProfitSharingTrust
Common shares without par value 63,903(2) I JaimeContrerasMarvan2006LivingTrust
Common shares without par value 02/15/2014 F 151 D $ 38.81 I Byspouse
1,915(3) I
Common shares without par value 02/17/2014 F 101 D $ 38.81 I Byspouse
1,814 I
Common shares without par value 02/18/2014 F 126 D $ 38.81 I Byspouse
1,688(3) I
Common shares without par value 02/18/2014 S 621 D $ 38.955 I Byspouse
1,067(3) I
Common shares without par value 16(1) I ProfitSharingTrust (byspouse)
Common shares without par value 12,081(4) I LivingTrust (byspouse)

2/19/2014

Page 2 of 2

SEC FORM 4

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned

(e.g., puts, calls, warrants, options, convertible securities)

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned(e.g., puts, calls, warrants, options, convertible securities) Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned(e.g., puts, calls, warrants, options, convertible securities) Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned(e.g., puts, calls, warrants, options, convertible securities) Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned(e.g., puts, calls, warrants, options, convertible securities) Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned(e.g., puts, calls, warrants, options, convertible securities) Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned(e.g., puts, calls, warrants, options, convertible securities) Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned(e.g., puts, calls, warrants, options, convertible securities) Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned(e.g., puts, calls, warrants, options, convertible securities) Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned(e.g., puts, calls, warrants, options, convertible securities) Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned(e.g., puts, calls, warrants, options, convertible securities) Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned(e.g., puts, calls, warrants, options, convertible securities) Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned(e.g., puts, calls, warrants, options, convertible securities) Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned(e.g., puts, calls, warrants, options, convertible securities) Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned(e.g., puts, calls, warrants, options, convertible securities) Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned(e.g., puts, calls, warrants, options, convertible securities) Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned(e.g., puts, calls, warrants, options, convertible securities)
1. Title ofDerivativeSecurity(Instr. 3) 2.Conversionor ExercisePrice ofDerivativeSecurity 3. TransactionDate(Month/Day/Year) 3A. DeemedExecution Date,if any(Month/Day/Year) 4.TransactionCode (Instr.8) 5.NumberofDerivativeSecuritiesAcquired(A) orDisposedof (D)(Instr. 3, 4and 5) 6. Date Exercisable andExpiration Date(Month/Day/Year) 7. Title andAmount ofSecuritiesUnderlyingDerivativeSecurity(Instr. 3 and 4) 8. Price ofDerivativeSecurity(Instr. 5) 9. NumberofderivativeSecuritiesBeneficiallyOwnedFollowingReportedTransaction(s) (Instr. 4) 10.OwnershipForm:Direct (D)or Indirect(I) (Instr. 4) 11. Natureof IndirectBeneficialOwnership(Instr. 4)
Code V (A) (D) DateExercisable ExpirationDate Title AmountorNumberofShares

Explanation of Responses:

  1. Balance in the Abbott Laboratories Stock Retirement Trust as of February 18, 2014.

  2. Held in the Jaime Contreras Marvan 2006 Living Trust. The reporting person is sole trustee of the trust. The trust is revocable.

  3. The reporting person disclaims beneficial ownership of all securities held by his spouse.

  4. Held in spouse's living trust. The reporting person's spouse is sole trustee of the trust. The trust is revocable. The reporting person disclaims beneficial ownership of these securities.

Remarks:

These transactions were made pursuant to a previously adopted plan complying with Rule 10b5-1(c).

John A. Berry, by power of 02/19/2014 attorney for Jaime Contreras

  • ** Signature of Reporting Person Date

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.

  • If the form is filed by more than one reporting person, see Instruction 4 (b)(v).

  • ** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).

  • Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.

Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

2/19/2014